Projects overview

Sort by

Toggle all information

ASAAP-plus | Clinical evaluation of AntimalarialS tri-therapy with AtovAquone-Proguanil for treatment of uncomplicated malaria in African children

01-01-2024

-

31-12-2025

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.0 Cross-cutting call topics
HORIZON-JU-GH-EDCTP3-2023-01
HORIZON-JU-GH-EDCTP3-2023-01-02 Funding to successfully finalise EDCTP2-funded clinical trials that were negatively impacted by the COVID-19 pandemic

4-CAGE-TB | Fortifying the automated smartphone-based Cough Audio classification for rapid triaGE testing for tuberculosis project

01-01-2025

-

31-12-2026

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.0 Cross-cutting call topics
HORIZON-JU-GH-EDCTP3-2023-01
HORIZON-JU-GH-EDCTP3-2023-01-02 Funding to successfully finalise EDCTP2-funded clinical trials that were negatively impacted by the COVID-19 pandemic

PROTID | Randomised Controlled Trial of Preventive Treatment of Latent Tuberculosis Infection in Patients with Diabetes Mellitus

01-07-2024

-

31-12-2026

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.0 Cross-cutting call topics
HORIZON-JU-GH-EDCTP3-2023-01
HORIZON-JU-GH-EDCTP3-2023-01-02 Funding to successfully finalise EDCTP2-funded clinical trials that were negatively impacted by the COVID-19 pandemic

PYRAPREG-extended | Efficacy and Safety of a newly registered Artemisinin-Based Combination (Pyronaridine-Artesunate -PYRAMAX®) for the treatment of uncomplicated malaria in African pregnant women - Extended

01-05-2024

-

30-04-2025

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.0 Cross-cutting call topics
HORIZON-JU-GH-EDCTP3-2023-01
HORIZON-JU-GH-EDCTP3-2023-01-02 Funding to successfully finalise EDCTP2-funded clinical trials that were negatively impacted by the COVID-19 pandemic

PEP4LEP 2.0 | PEP4LEP 2.0 - Chemoprohylaxis for leprosy: comparing the effectiveness and feasibility of a community-based intervention to a health centre-based intervention in Ethiopia, Mozambique, and Tanzania.

01-04-2024

-

31-03-2026

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.0 Cross-cutting call topics
HORIZON-JU-GH-EDCTP3-2023-01
HORIZON-JU-GH-EDCTP3-2023-01-02 Funding to successfully finalise EDCTP2-funded clinical trials that were negatively impacted by the COVID-19 pandemic

The META Trial | PREVENTING AND DELAYING THE DEVELOPMENT OF DIABETES IN AFRICA: A RANDOMISED PLACEBO -CONTROLLED DOUBLE-BLIND PHASE III TRIAL OF METFORMIN IN HIV-INFECTED PERSONS WITH PRE-DIABETES

01-01-2025

-

31-12-2026

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.0 Cross-cutting call topics
HORIZON-JU-GH-EDCTP3-2023-01
HORIZON-JU-GH-EDCTP3-2023-01-02 Funding to successfully finalise EDCTP2-funded clinical trials that were negatively impacted by the COVID-19 pandemic

INTENSE-TBM-2 | Intensified tuberculosis treatment to reduce the high mortality of tuberculous meningitis in HIV-infected and uninfected patients

01-01-2025

-

31-12-2026

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.0 Cross-cutting call topics
HORIZON-JU-GH-EDCTP3-2023-01
HORIZON-JU-GH-EDCTP3-2023-01-02 Funding to successfully finalise EDCTP2-funded clinical trials that were negatively impacted by the COVID-19 pandemic
Powered by Chris Decubber BV